Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 January 2008

Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration

L. R. Chiarelli, M. Molinaro, C. Libetta, C. Tinelli, L. Cosmai, G. Valentini, A. Dal Canton, M. Regazzi

Ann Transplant 2008; 13(1): 42-42 :: ID: 880208


Background: Long-term therapy with MMF may induce IMPDH activity in peripheral blood mononuclear cells (MNC), reducing its immunosuppressive properties.
Material/Methods: IMPDH activity was measured in MNCs samples from 73 stable kidney transplant patients (median treatment time: 34 months, range: 3-75), before (t0) and 2 hours after (t2) MMF administration and monitored for up to 12 months. MMF treatment was combined with cyclosporine (CsA group) in 24 subjects, tacrolimus (TAC group) in 33, and sirolimus (SRL group) in 16. Samples from 95 healthy subjects were used as controls.
Results: IMPDH activity in healthy subjects was highly variable, mean 8.33±6.93 nmol/h/mg, with no relevant association with sex or age. In transplant recipients, during 12 months of MMF therapy, t0 IMPDH activity increased from 5.5±3.93 to 11.66±6.45 nmol/h/mg, with considerable intra- and interpatient variability (about 60%), and with no decrease in inhibition level (73.3%, range: 54.0-96.6). No significant intergroup differences were found. Mean concentrations of CsA, TAC, SRL and MPA were 142.4, 9.4, 12.9 ng/ml and 3.38 μg/ml. Four patients experienced acute rejection (AR) during the 12-month follow-up. IMPDH activity at t0 was increased during rejection versus non-rejection in 3 patients. No differences in enzyme inhibition levels were observed.
Conclusions: Despite the association found between IMPDH activity and AR, the high intrapatient variability affects its effectiveness as a predictive tool in long-term transplant outcomes. Further trials, also including pre-transplant data on both IMPDH expression and biological activity, are warranted to better assess the rule of IMPDH activity as biomarker for MPA effect in clinical practice.

Keywords: Mycophenolate Mofetil, combined therapy, Pulsed Doppler tissue imaging Dobutamine stress echocardiography

Add Comment 0 Comments

In Press

Original article  

Post-Donation Regret and Anxiety Among Family Living Liver Donors: The Mediating Roles of Family Relationsh...

Ann Transplant In Press; DOI: 10.12659/AOT.944176  

Original article  

Effect of the Organ Donation Quality System on Donation Activity of Warsaw Hospitals

Ann Transplant In Press; DOI: 10.12659/AOT.943520  

Original article  

Clonal Hematopoiesis-Associated Gene Mutations Affect Acute Graft-Versus-Host Disease After Hematopoietic S...

Ann Transplant In Press; DOI: 10.12659/AOT.943688  

Original article  

Impact of Recipient and Donor Body Mass Index on Survival Outcomes After Intestinal Transplantation: A Unit...

Ann Transplant In Press; DOI: 10.12659/AOT.943994  

Most Viewed Current Articles

05 Apr 2022 : Original article   12,201

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   8,720

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

12 Jan 2022 : Original article   8,640

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

15 Mar 2022 : Case report   6,496

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358